Submitted by Anonymous (not verified) on 10 June 2026 - 15:22
Human medicines European public assessment report (EPAR): Byannli (previously Paliperidone Janssen-Cilag International), paliperidone, Date of authorisation: 18/06/2020, Revision: 5, Status: Authorised
Source: